Is there a new place for mitoxantrone in the treatment of multiple sclerosis?

CONCLUSIONS AND CLINICAL IMPLICATIONS: Mitoxantrone can be considered as a valuable therapeutic option for patients who are on the borderline of RRMS and SPMS. PMID: 31922582 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31922582?dopt=Abstract

Source: Neurologia i Neurochirurgia Polska - January 9, 2020 Category: Neurology Authors: Wawrzyniak S, Rzepiński Ł Tags: Neurol Neurochir Pol Source Type: research